Tobias Peikert
Mayo Clinic
CancerRadiologySurgeryPathologyOncologyAntibodyImmunologyAnti-neutrophil cytoplasmic antibodyLung cancerLung cancer screeningMesotheliomaLungNodule (medicine)Latent tuberculosisRituximabAdenocarcinomaCancer researchMedicineBiologyGastroenterology
Publications 186
#1Michael A. Barry (Mayo Clinic)H-Index: 46
Last. Olivier G
view all 19 authors...
SARS-CoV-2 enters the body at mucosal surfaces, such as the nose and lungs. These events involve a small number of virions at these mucosal barriers and are therefore a strategic point to stop a COVID-19 infection before it starts. Despite this, most vaccines against COVID-19 are being injected into the muscle where they will not generate the highest levels of mucosal protection. The vaccines that are approved for use in humans are all replication-defective (RD) mRNA, DNA, or adenovirus (Ad) vac...
#1Fabien Maldonado (VUMC: Vanderbilt University Medical Center)H-Index: 31
#2Cyril Varghese (Mayo Clinic)H-Index: 3
Last. Tobias Peikert (Mayo Clinic)H-Index: 29
view all 13 authors...
2 CitationsSource
#1Gregory R. Stroh (Mayo Clinic)H-Index: 1
#2Tobias Peikert (Mayo Clinic)H-Index: 29
Last. Patricio Escalante (Mayo Clinic)H-Index: 14
view all 3 authors...
BACKGROUND Immune checkpoint inhibitors (ICIs) blocking inhibitory immune pathways (e.g., programmed cell death protein-1/-ligand1 [PD-1/PD-L1]) have revolutionized cancer therapy for numerous malignancies. There have been an increasing number of cases of active tuberculosis (TB) reported in association with ICI use, and recent data suggest alterations in immune responses in TB by ICI. The aim of this study was to characterize the frequency of latent tuberculosis infection (LTBI) and active TB i...
#1William Breen (Mayo Clinic)H-Index: 4
#2Elizabeth B. Jeans (Mayo Clinic)H-Index: 3
Last. Dawn Owen (Mayo Clinic)H-Index: 15
view all 14 authors...
Abstract Background Ultracentral lung cancers arise near the proximal bronchial tree (PBT), trachea, or esophagus, and have been associated with worse outcomes and increased toxicity after radiotherapy. We sought to associate dosimetric and anatomic factors with oncologic outcomes and toxicities. Methods One-hundred ten patients treated with ablative, curative-intent radiotherapy for ultracentral, node-negative, non-small cell lung cancer were included. Dosimetric and geometric data obtained usi...
#1Mohamed F. Ali (Mayo Clinic)H-Index: 3
#2Ashley M. Egan (Mayo Clinic)H-Index: 2
Last. Eva M. Carmona (Mayo Clinic)H-Index: 17
view all 12 authors...
B-cell activation is increasingly linked to numerous fibrotic lung diseases and it is well-known that aggregates of lymphocytes form in the lung of many of these patients (1, 2). Activation of B-cells by pattern recognition receptors (PRR) drives the release of inflammatory cytokines, chemokines and metalloproteases important in the pathophysiology of pulmonary fibrosis (3-6). However, the specific mechanisms of B-cell activation in patients with idiopathic pulmonary fibrosis (IPF) are poorly un...
#1John P. Welby (Mayo Clinic)H-Index: 5
#2Erin A. Fender (Mayo Clinic)H-Index: 9
Last. Erica M. Knavel-Koepsel (Mayo Clinic)
view all 6 authors...
Last. Tobias PeikertH-Index: 29
view all 5 authors...